Back

Fibroblasts-derived from Pluripotent Cells Harboring a Single Allele Knockout in Two Pluripotency Genes Exhibit DNA Methylation Abnormalities and pluripotency induction Defects

Lasry, R.; Maoz, N.; Cheng, A. W.; Yom Tov, N.; Kulenkampff, E.; Azagury, M.; Yang, H.; Ople, C.; Markoulaki, S.; Faddah, D. A.; Makedonski, K.; Sabbag, O.; Jaenisch, R.; Buganim, Y.

2022-05-19 cell biology
10.1101/2022.05.18.492474 bioRxiv
Show abstract

A complete knockout (KO) of a single key pluripotency gene has been shown to drastically affect embryonic stem cell (ESC) function and epigenetic reprogramming. However, knockin (KI)/KO of a reporter gene only in one of two alleles in a single pluripotency gene is considered harmless and is largely used in the stem cell field. Here, we sought to understand the impact of simultaneous elimination of a single allele in two ESC key genes on pluripotency potential and acquisition. We established multiple pluripotency systems harboring KI/KO in a single allele of two different pluripotency genes (i.e. Nanog+/-; Sall4+/-, Nanog+/-; Utf1+/-, Nanog+/-; Esrrb+/- and Sox2+/-; Sall4+/-). Interestingly, although these double heterozygous mutant lines maintain their stemness and contribute to chimeras equally to their parental control cells, fibroblasts derived from these systems show a significant reduction in their capability to induce pluripotency either by Oct4, Sox2, Klf4 and Myc (OSKM) or by nuclear transfer (NT). Tracing the expression of Sall4 and Nanog, as representative key pluripotency targeted genes, at early phases of reprogramming could not explain the seen delay/blockage. Further exploration identifies abnormal methylation landscape around pluripotent and developmental genes in the double heterozygous mutant fibroblasts. Accordingly, treatment with 5-azacytidine two days prior to transgene induction rescues the reprogramming defects. This study emphasizes the importance of maintaining two intact alleles for pluripotency induction and suggests that insufficient levels of key pluripotency genes leads to DNA methylation abnormalities in the derived-somatic cells later on in development.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Stem Cell Reports
118 papers in training set
Top 0.1%
14.2%
2
Stem Cell Research
16 papers in training set
Top 0.1%
14.2%
3
Stem Cells
28 papers in training set
Top 0.1%
14.2%
4
Scientific Reports
3102 papers in training set
Top 4%
12.2%
50% of probability mass above
5
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 0.3%
9.1%
6
PLOS ONE
4510 papers in training set
Top 40%
3.6%
7
iScience
1063 papers in training set
Top 8%
2.6%
8
Biology Open
130 papers in training set
Top 0.5%
2.6%
9
Cells
232 papers in training set
Top 2%
1.9%
10
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.9%
11
Stem Cell Research & Therapy
30 papers in training set
Top 0.4%
1.7%
12
Genes
126 papers in training set
Top 1%
1.5%
13
Biochemistry and Biophysics Reports
28 papers in training set
Top 1%
0.9%
14
Molecular Biology Reports
19 papers in training set
Top 0.4%
0.9%
15
Stem Cells Translational Medicine
11 papers in training set
Top 0.1%
0.9%
16
Cytotherapy
14 papers in training set
Top 0.3%
0.9%
17
Biochemical and Biophysical Research Communications
78 papers in training set
Top 2%
0.8%
18
Nature Communications
4913 papers in training set
Top 63%
0.7%
19
Epigenomics
10 papers in training set
Top 0.1%
0.7%
20
Epigenetics & Chromatin
42 papers in training set
Top 0.4%
0.7%
21
PLOS Genetics
756 papers in training set
Top 17%
0.6%
22
Computational Biology and Chemistry
23 papers in training set
Top 0.7%
0.6%